You may already have heard the news that Roche have decided to close the GENERATION HD1 and GEN-EXTEND studies early. Whilst this is disappointing news for the whole HD community, the lessons learnt from this work will undoubtedly help us take forward future potential disease modifying therapies in HD that are already in the planning.